Company Filing History:
Years Active: 2017-2024
Title: The Innovative Contributions of Inventor Sunbae Lee in Biomedicine
Introduction: Sunbae Lee, a prominent inventor based in Daejeon, South Korea, has made significant strides in the field of biomedicine through his innovative work. With a total of four patents to his name, Lee's research primarily focuses on antibody-drug conjugates, aiming to improve therapeutic strategies for cancer treatment.
Latest Patents: Among Sunbae Lee's recent innovations are two groundbreaking patents. The first is for an antibody-drug conjugate comprising a modified antibody that includes a specific motif at the end of the antibody, enhancing the conjugation yield of the drug. This development promises to advance the efficacy of treatments by utilizing a modified antibody-drug conjugate (mADC) characterized by its improved structure and composition.
The second patent revolves around a modified antibody specifically targeting folate receptor alpha (FOLR1). This invention involves an antibody that blocks FOLR1's activity with an increased affinity, making it a promising candidate for the prevention and treatment of cancer proliferative disorders associated with heightened FOLR1 expression.
Career Highlights: Sunbae Lee currently works at Alteogen, Inc., a company renowned for its commitment to innovative biopharmaceutical solutions. His expertise and inventions contribute to the organization’s mission of developing advanced medical therapies, particularly in the realm of oncology.
Collaborations: Throughout his career, Lee has collaborated with notable colleagues, including Soon Jae Park and Hye-Shin Chung. These partnerships have fostered a dynamic environment for innovation, enabling the exchange of ideas that drive research forward.
Conclusion: Sunbae Lee's contributions to the field of biomedicine, particularly through his patents related to antibody-drug conjugates, exemplify the pivotal role inventors play in advancing healthcare solutions. His dedication to research and collaboration positions him as a key innovator in the fight against cancer, promising hope through his groundbreaking work.